Tel Aviv Stock Exchange: Trade Opening By The Management Of Newest TA-100 Constituents

TASE management joined by the management of the newest constituents to the TA-100 index opened trade on the morning of December 16, 2012.

4 of the 6 companies joining the index are "biomed" companies.

Photographed (from left to right) : Dr. Anat Cohen-Dayag, CEO Compugen; Ofer Haviv, CEO Evogene; Ester Levanon, CEO TASE; Zami Aberman, CEO Pluristem Therapeutics, David Tsur, CEO Kamada; and Alex Lifshitz, Senior Executive Ashtrom Properties

Photograph: Israel Malovani